CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $20,406,000 | -30.9% | 872,415 | -14.9% | 4.22% | -12.0% |
Q4 2020 | $29,514,000 | -49.1% | 1,024,800 | -64.2% | 4.79% | -8.1% |
Q3 2020 | $57,983,000 | -44.6% | 2,861,924 | -17.8% | 5.22% | -37.6% |
Q2 2020 | $104,574,000 | +68.3% | 3,480,000 | +76.0% | 8.36% | +28.7% |
Q1 2020 | $62,153,000 | +16.2% | 1,977,502 | +74.2% | 6.49% | +39.5% |
Q4 2019 | $53,476,000 | – | 1,135,122 | – | 4.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |